NEW YORK - Indaptus Therapeutics, Inc. (NASDAQ:INDP), a clinical-stage biotechnology company with a market capitalization of approximately $13 million, has received authorization from Health Canada to ...

The German automaker has seen sales stall, quality concerns rise and its electric vehicle initiatives fail, leading the board ...

BBVA SA is changing the way it manages its balance sheet as it taps into increased demand for deals that transfer risk out of ...